Cargando…
Clinical Impact of the CYP2C19 Gene on Diazepam for the Management of Alcohol Withdrawal Syndrome
Diazepam is a benzodiazepine widely prescribed for the management of patients with severe alcohol withdrawal syndrome to prevent agitation, withdrawal seizures, and delirium tremens. Despite standard dosing of diazepam, a subset of patients experience refractory withdrawal syndromes or adverse drug...
Autores principales: | Ho, Teresa T., Noble, Melissa, Tran, Bao Anh, Sunjic, Katlynd, Gupta, Sheeba Varghese, Turgeon, Jacques, Crutchley, Rustin D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961427/ https://www.ncbi.nlm.nih.gov/pubmed/36836519 http://dx.doi.org/10.3390/jpm13020285 |
Ejemplares similares
-
Determinants of success of loading dose diazepam for alcohol withdrawal: A chart review
por: Bharadwaj, Balaji, et al.
Publicado: (2012) -
Sub-Analysis of CYP-GUIDES Data: Assessing the Prevalence and Impact of Drug-Gene Interactions in an Ethnically Diverse Cohort of Depressed Individuals
por: Crutchley, Rustin D., et al.
Publicado: (2022) -
Preventive Effects of Baclofen but Not Diazepam on Hippocampal Memory and Glucocorticoid Alterations After Prolonged Alcohol Withdrawal in Mice
por: Nadia, Henkous, et al.
Publicado: (2022) -
Proteomics and weighted gene correlated network analysis reveal glutamatergic synapse signaling in diazepam treatment of alcohol withdrawal
por: Kong, Wan, et al.
Publicado: (2023) -
Production of Bi-Compartmental Tablets by FDM 3D Printing for the Withdrawal of Diazepam
por: Macedo, Joana, et al.
Publicado: (2023)